Michelle Drerup, PsyD, discusses patients' complex & challenging management of fibromyalgia and sleep disorders.

Relative risks for all-cause, cardiovascular, and respiratory mortality were larger for fire-related PM2.5 than total PM2.5.

Topline results were announced from a phase 3 trial evaluating efgartigimod alfa-fcab in patients with AChR-Ab seronegative generalized myasthenia gravis.

In October 2024, Imuldosa received approval from the Food and Drug Administration based on data from the phase 3 Opportuniti ...

Inhalational exposures to smoking, asbestos, dust, metals, and organics significantly increase the odds of developing interstitial lung disease.

Patients with severe psoriasis who were treated with TNFi long-term had a lower risk of developing PsA than those treated with phototherapy.

Older age and prior b/tsDMARDs exposure were associated with more severe ultrasound-detected inflammatory and structural changes in patients with PsA.

Five key updates to the language describing Sjögren disease offer clearer communication for patients, and may improve research.

Hematologic and solid tumor cancer risks were significantly higher among patients with SSc vs the general population in South Korea, particularly within 1 year of diagnosis.

Treatment with guselkumab led to rapid and sustained improvements in clinical and patient-reported outcomes among biologic-naïve adults with severe PsA.

Significant improvement was seen in motor function for patients with spinal muscular atrophy receiving apitegromab vs placebo.

Anti-Ro52 seropositivity is linked to increased rates of ILD progression and a decrease in progression-free and transplant-free survival.